Yahoo Web Search

  1. Ad
    related to AbbVie Inc
  1. AbbVie (ABBV) Earnings Expected to Grow: Should You Buy?

    Zacks via Yahoo FinanceApr 18 14:33 PM

    Wall Street expects a year-over-year increase in earnings on lower revenues when AbbVie (ABBV) reports results for the quarter ended March 2019. While this widely-known consensus outlook ...

  2. AbbVie Inc (ABBV) Q1 2019 Earnings Call Transcript

    Motley Fool via Yahoo FinanceApr 25 21:03 PM

    AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking ...

  3. AbbVie Inc. ABBV posted better-than-expected first-quarter 2018 earnings and revenues. The company also raised its guidance for adjusted earnings per share (“EPS”) for 2019. Earnings ...

  4. Johnson & Johnson JNJ will report first-quarter 2019 results on Apr 6, before market open. In the last reported quarter, the company delivered a positive earnings surprise of 1.03%. J&J’s performance ...

  5. AbbVie Is Losing Its Humira Safety Blanket

    Bloomberg via Yahoo FinanceApr 25 15:13 PM

    AbbVie was still able to increase its 2019 earnings guidance and consistently projects confidence about its ability to replace a medicine that accounts for more than 60 percent of its ...

  6. AbbVie (ABBV) Beats Q1 Earnings and Revenues, Shares Up

    Zacks via Yahoo FinanceApr 25 12:50 PM

    While Humira will remain the key growth driver at AbbVie, Imbruvica and Mavyret are fast becoming important revenue generators. AbbVie's performance has been mixed, with the pharmaceuticals ...

  7. In that same time, the Medical sector gained 1.2%, while the S&P 500 gained 3.84%. ABBV will be looking to display strength as it nears its next earnings release, which is expected to be April ...

  8. AbbVie (ABBV) Gains As Market Dips: What You Should Know

    Zacks via Yahoo FinanceApr 15 21:45 PM

    AbbVie (ABBV) closed the most recent trading day at $81.01, moving +0.28% from the previous trading session. ABBV will be looking to display strength as it nears its next earnings release ...

  9. Analyst Note Fosters Doubts About Dow Inc Stock

    InvestorPlace via Yahoo FinanceApr 10 15:00 PM

    Shares of the now-independent Dow Inc (NYSE:DOW) declined on Friday for the first time since the company was spun off . In his report, he noted that DOW has a higher dividend than its peers.

  10. Humira sales have accounted for the bulk of AbbVie's total revenue for years and the drug has grown to become the world's best-selling prescription medicine.

  1. Ad
    related to AbbVie Inc